Previous Article | Next Article 
Journal of Clinical Microbiology, March 2003, p. 1080-1086, Vol. 41, No. 3
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.3.1080-1086.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
International Proficiency Study of a Consensus L1 PCR Assay for the Detection and Typing of Human Papillomavirus DNA: Evaluation of Accuracy and Intralaboratory and Interlaboratory Agreement
Janet R. Kornegay,1 Michel Roger,2,3 Philip O. Davies,4 Amanda P. Shepard,1 Nayana A. Guerrero,5 Belen Lloveras,5 Darren Evans,4 and François Coutlée1,2,3*
Roche Molecular Systems Inc., Alameda, California,1
Département de Microbiologie et Infectiologie, Hôpital Notre-Dame du Centre Hospitalier de l'Université de Montréal,2
Département de Microbiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada;,3
BMI, London, United Kingdom,4
Department of Pathology, CSU Bellvitge/Lab. Recerca Translacional, Institut Catala d'Oncologia, Barcelona, Spain5
Received 24 May 2002/
Returned for modification 26 August 2002/
Accepted 9 December 2002
The PGMY L1 consensus primer pair combined with the line blot assay allows the detection of 27 genital human papillomavirus (HPV) genotypes. We conducted an intralaboratory and interlaboratory agreement study to assess the accuracy and reproducibility of PCR for HPV DNA detection and typing using the PGMY primers and typing amplicons with the line blot (PGMY-LB) assay. A test panel of 109 samples consisting of 29 HPV-negative (10 buffer controls and 19 genital samples) and 80 HPV-positive samples (60 genital samples and 20 controls with small or large amounts of HPV DNA plasmids) were tested blindly in triplicate by three laboratories. Intralaboratory agreement ranged from 86 to 98% for HPV DNA detection. PGMY-LB assay results for samples with a low copy number of HPV DNA were less reproducible. The rate of intralaboratory agreement excluding negative results for HPV typing ranged from 78 to 96%. Interlaboratory reliability for HPV DNA positivity and HPV typing was very good, with levels of agreement of >95% and kappa values of >0.87. Again, low-copy-number samples were more prone to generating discrepant results. The accuracy varied from 91 to 100% for HPV DNA positivity and from 90 to 100% for HPV typing. HPV testing can thus be accomplished reliably with PCR by using a standardized written protocol and quality-controlled reagents. The use of validated HPV DNA detection and typing assays demonstrating excellent interlaboratory agreement will allow investigators to better compare results between epidemiological studies.
* Corresponding author. Mailing address: Département de Microbiologie et Infectiologie, Hôpital Notre-Dame du Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke est, Montréal, Québec H2L 4M1, Canada. Phone: (514) 890-8000, ext. 25162. Fax: (514) 412-7512. E-mail:
francois.coutlee{at}ssss.gouv.qc.ca.
Journal of Clinical Microbiology, March 2003, p. 1080-1086, Vol. 41, No. 3
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.3.1080-1086.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wolffs, P. F. G., Vink, C., Keijdener, J., Habek, B., Reijans, M., Simons, G., Bruggeman, C. A., van den Brule, A. J. C.
(2009). Evaluation of MeningoFinder, a Novel Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Six Virus Species Causing Central Nervous System Infections. J. Clin. Microbiol.
47: 2620-2622
[Abstract]
[Full Text]
-
Koshiol, J., Lindsay, L., Pimenta, J. M., Poole, C., Jenkins, D., Smith, J. S.
(2008). Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis. Am J Epidemiol
168: 123-137
[Abstract]
[Full Text]
-
van Hamont, D., van Ham, M. A. P. C., Bakkers, J. M. J. E., Massuger, L. F. A. G., Melchers, W. J. G.
(2006). Evaluation of the SPF10-INNO LiPA Human Papillomavirus (HPV) Genotyping Test and the Roche Linear Array HPV Genotyping Test.. J. Clin. Microbiol.
44: 3122-3129
[Abstract]
[Full Text]
-
Coutlee, F., Rouleau, D., Petignat, P., Ghattas, G., Kornegay, J. R., Schlag, P., Boyle, S., Hankins, C., Vezina, S., Cote, P., Macleod, J., Voyer, H., Forest, P., Walmsley, S., The Canadian Women's HIV Study Group, , Franco, E.
(2006). Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test.. J. Clin. Microbiol.
44: 1998-2006
[Abstract]
[Full Text]
-
Suba, E. J., Murphy, S. K., Donnelly, A. D., Furia, L. M., Huynh, M. L. D., Raab, S. S.
(2006). Systems Analysis of Real-World Obstacles to Successful Cervical Cancer Prevention in Developing Countries. AJPH
96: 480-487
[Abstract]
[Full Text]
-
Quint, W. G. V., Pagliusi, S. R., Lelie, N., de Villiers, E.-M., Wheeler, C. M., the World Health Organization Human Papillomavirus,
(2006). Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA. J. Clin. Microbiol.
44: 571-579
[Abstract]
[Full Text]